68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?

Nucl Med Mol Imaging. 2019 Dec;53(6):442-445. doi: 10.1007/s13139-019-00621-x. Epub 2019 Nov 11.

Abstract

We report a case of a 47-year-old female known with metastatic papillary thyroid cancer. Her treatment history included total thyroidectomy and 3 previous radio ablations with a cumulative dose of 950 mCi of 131I. On follow-up, her thyroglobulin levels had demonstrated a rising trend (from 3789.0 to 4240.0 ug/L) despite a 123I whole-body scan demonstrating a reduction in tracer avid lesions. She was suspected of having radio-resistant disease. The patient underwent both 18F-FDG and 68Ga-PSMA PET/CT imaging with both scans demonstrating congruent lesions however with far greater intensity on the 68Ga-PSMA study.

Keywords: 18F-FDG; 68Ga-PSMA; Radioactive iodine refractory thyroid; Thyroid cancer.